StockData
Tiziana Life Sciences Ltd logo

Tiziana Life Sciences Ltd (TLSA) income statement

TLSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on May 1, 2026Score 3/30
$0.65+0.07 (+12.07%)

Close on Nov 17, 2026Market cap $78.33MP/E –Yield –

Tiziana Life Sciences Ltd income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
–

Financial strength

Current ratio
0.76
Debt to equity
–
Debt to assets
–
Cash to current liabilities
35.8%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?